Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma
Authors
Keywords
-
Journal
ANNALS OF HEMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-27
DOI
10.1007/s00277-018-3502-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation
- (2018) Makoto Yoshimitsu et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection
- (2017) Daisuke Kuroda et al. Gastric Cancer
- Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation
- (2017) Shigeo Fuji et al. HAEMATOLOGICA
- Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation
- (2017) Shigeo Fuji et al. HAEMATOLOGICA
- Prognostic impact of controlling nutritional status score in resected lung squamous cell carcinoma
- (2017) Gouji Toyokawa et al. Journal of Thoracic Disease
- Deep sequencing of the T cell receptor visualizes reconstitution of T cell immunity in mogamulizumab-treated adult T cell leukemia
- (2017) Takero Shindo et al. OncoImmunology
- The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study
- (2016) Takahiro Toyokawa et al. BMC CANCER
- Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality
- (2016) Shigeo Fuji et al. JOURNAL OF CLINICAL ONCOLOGY
- Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia
- (2016) H. Ureshino et al. Cancer Immunology Research
- A Retrospective Analysis of Treatment Outcomes in Adult T Cell Leukemia/Lymphoma Patients with Aggressive Disease Treated with or without Allogeneic Stem Cell Transplantation: A Single-Center Experience
- (2015) Hideaki Kawada et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma
- (2015) S Fuji et al. BONE MARROW TRANSPLANTATION
- Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study
- (2015) Youko Suehiro et al. BRITISH JOURNAL OF HAEMATOLOGY
- Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study
- (2015) Takashi Ishida et al. BRITISH JOURNAL OF HAEMATOLOGY
- Impact of the Preoperative Controlling Nutritional Status (CONUT) Score on the Survival after Curative Surgery for Colorectal Cancer
- (2015) Yasuhito Iseki et al. PLoS One
- Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A)
- (2014) Takuya Fukushima et al. BRITISH JOURNAL OF HAEMATOLOGY
- Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans
- (2013) D. Sugiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
- Unrelated cord blood transplantation for patients with adult T-cell leukemia/lymphoma: experience at a single institute
- (2012) Takayuki Nakamura et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Long-Term Persistence of Limited HTLV-I Tax-specific Cytotoxic T Cell Clones in a Patient with Adult T Cell Leukemia/Lymphoma after Allogeneic Stem Cell Transplantation
- (2012) Yukie Tanaka et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Prognostic Index for Acute- and Lymphoma-Type Adult T-Cell Leukemia/Lymphoma
- (2012) Hiroo Katsuya et al. JOURNAL OF CLINICAL ONCOLOGY
- Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
- (2012) Takashi Ishida et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers
- (2011) Ayako Takamori et al. Retrovirology
- Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study
- (2010) M. Hishizawa et al. BLOOD
- Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer
- (2008) Ian D. Schnadig et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started